Sandu Pharmaceuticals share news, announcements and annual reports
BSE: 524703Pharmaceuticals & BiotechnologySmall Cap
Sandu Pharmaceuticals Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 1994
Last close ₹35.95up ₹0.64 (1.81%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹35.31.
30 Oct: open ₹35.56, high ₹36.40, low ₹35.01
52-week range of traded prices to 30 Oct 2026
₹30.00Low, 30 Mar 2026₹50.00High, 27 Apr 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹35 Cr3,677th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 19.61
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.80
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.78%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 4.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 5.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,591
Sandu Pharmaceuticals board meetings
142 filed, newest first. Page 2 of 3.
Feb 2023
Nov 2022
14 Nov · Board meeting
1 Nov · Board meeting
Meeting on 14 Nov 2022: quarterly results
Aug 2022
29 Aug · Board meeting
12 Aug · Board meeting
1 Aug · Board meeting
Meeting on 12 Aug 2022: quarterly results and dividend
Jul 2022
30 Jul · Board meeting
7 Jul · Board meeting
4 Jul · Board meeting
Meeting on 7 Jul 2022
May 2022
30 May · Board meeting
16 May · Board meeting
Meeting on 30 May 2022: audited results
Feb 2022
7 Feb · Board meeting
Meeting on 14 Feb 2022: quarterly results
Nov 2021
29 Nov · Board meeting
25 Nov · Board meeting
Meeting on 29 Nov 202113 Nov · Board meeting
1 Nov · Board meeting
Meeting on 13 Nov 2021: quarterly results
Oct 2021
Aug 2021
14 Aug · Board meeting
3 Aug · Board meeting
3 Aug · Board meeting
Meeting on 14 Aug 2021: quarterly results and dividend
Jun 2021
30 Jun · Board meeting
21 Jun · Board meeting
Meeting on 30 Jun 2021: audited results10 Jun · Board meeting
2 Jun · Board meeting
Meeting on 10 Jun 2021
Feb 2021
13 Feb · Board meeting
1 Feb · Board meeting
Meeting on 13 Feb 2021: quarterly results
Nov 2020
13 Nov · Board meeting
5 Nov · Board meeting
Meeting on 13 Nov 2020: quarterly results
Sep 2020
4 Sep · Board meeting
Meeting on 14 Sep 2020: quarterly results
Aug 2020
31 Aug · Board meeting
Meeting on 3 Sep 2020: issue of warrants27 Aug · Board meeting
Meeting on 29 Aug 2020: issue of warrants
Jul 2020
31 Jul · Board meeting